Singapore markets open in 1 hour 14 minutes

Nuvation Bio Inc. (NUVB)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.99000.0000 (0.00%)
At close: 04:00PM EST
1.9900 0.00 (0.00%)
After hours: 04:01PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.9900
Open1.9800
Bid1.9800 x 1400
Ask2.0300 x 1000
Day's range1.9100 - 2.0300
52-week range1.7400 - 10.2800
Volume709,457
Avg. volume640,965
Market cap434.602M
Beta (5Y monthly)0.48
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update

    NEW YORK, November 03, 2022--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the third quarter ended September 30, 2022, and provided a business update.

  • Business Wire

    Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update

    NEW YORK, August 04, 2022--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the second quarter ended June 30, 2022, and provided a business update.

  • Business Wire

    Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development Program

    NEW YORK, August 01, 2022--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced that it will prioritize NUV-868 and development of its novel small molecule DDC platform and discontinue clinical development of NUV-422.